Patent ID: 8722669

Claim:
A method of treating macular degeneration in a subject, the method comprising: administering to the subject in need thereof a therapeutically effective amount of a primary amine compound of the formula: wherein R 2 is hydrogen or (C 1 -C 6 ) straight chain or branched unsubstituted or substituted alkyl; R 3 is straight or branched unsubstituted or substituted alkyl of from 1 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, -phenyl or substituted phenyl; R 4 is hydrogen or (C 1 -C 6 ) straight chain or branched unsubstituted or substituted alkyl, or carboxyl; as well as pharmaceutically acceptable salts thereof.